Mitragotri S
Department of Chemical Engineering, University of California, Santa Barbara 93106, USA.
Pharm Res. 2001 Jul;18(7):1018-23. doi: 10.1023/a:1010952731205.
Applications of transdermal drug delivery are limited by low skin permeability. Several chemicals have been used to enhance transdermal drug transport, many of which enhance skin permeability by disordering lipid bilayers. The objective of this study was to develop a mathematical model to describe the effect of bilayer disrupting agents on skin permeability to low molecular weight hydrophobic drugs.
I predicted solute partition and diffusion coefficients in the lipid bilayers of the stratum corneum using scaled particle theory, which calculates these coefficients based on the work required to create a cavity to incorporate the solute in the lipid bilayer.
Model equations predicted that no significant permeability enhancement would be observed for small solutes (MW < 100). Thereafter, the enhancement, E, increases with solute cross-sectional area. The resulting equation to predict the enhancement of skin permeability is given by E = exp[alpha(r2 - 8.7)], where r is solute molecular radius in angstroms and alpha is the degree of bilayer disorder. Predictions of the model were compared with the experimental data collected from several studies.
The model predictions compare well with the experimental data.
透皮给药的应用受到皮肤低渗透性的限制。几种化学物质已被用于增强透皮药物转运,其中许多通过扰乱脂质双层来提高皮肤渗透性。本研究的目的是建立一个数学模型,以描述双层破坏剂对皮肤对低分子量疏水药物渗透性的影响。
我使用缩放粒子理论预测角质层脂质双层中的溶质分配系数和扩散系数,该理论根据在脂质双层中创建一个容纳溶质的空腔所需的功来计算这些系数。
模型方程预测,对于小溶质(分子量<100),不会观察到显著的渗透性增强。此后,增强因子E随溶质横截面积增加。预测皮肤渗透性增强的所得方程为E = exp[α(r2 - 8.7)],其中r是溶质分子半径(单位为埃),α是双层紊乱程度。将该模型的预测结果与多项研究收集的实验数据进行了比较。
模型预测结果与实验数据吻合良好。